Marquita Camilleri
72 Huntley Street
London, ENG WC1E6DD, United Kingdom
London, ENG WC1E6DD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.
Journal: EJHaem
Published: April 03, 2024
High patient satisfaction and increased physical activity following a remote multidisciplinary team multiple myeloma clinic.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 13, 2022
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
Journal: The Lancet. Haematology
Published: July 22, 2022
Adaptation of a multiple myeloma minimal residual disease multicolor flow cytometry assay for real-world practice.
Journal: Cytometry. Part B, Clinical cytometry
Published: April 18, 2022
The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 25, 2022
Applying current smouldering myeloma risk models to a UK single-centre cohort and clinical features at progression.
Journal: British journal of haematology
Published: September 25, 2021
Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience.
Journal: Leukemia & lymphoma
Published: August 04, 2021
Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients.
Journal: Leukemia & lymphoma
Published: June 24, 2021
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
Journal: British journal of haematology
Published: December 24, 2020
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial.
Journal: British journal of haematology
Published: November 22, 2020
Leishmaniasis as an unusual cause of pancytopenia in a patient receiving immunomodulatory therapy for myeloma.
Journal: British journal of haematology
Published: April 24, 2020
Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases.
Journal: Annals of hematology
Published: June 10, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026